Skip to content

A Comparative Clinical Study to Evaluate the Efficacy and Safety of Emotion to Emotion Therapy Versus VR-based Emotion-Emotion Thearpy for Treatment of Hwa-byung

A Comparative Clinical Study to Evaluate the Efficacy and Safety of Emotion to Emotion Therapy Versus VR-based Emotion-Emotion Thearpy for Treatment of Hwa-byung

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0007871
Enrollment
96
Registered
2022-11-03
Start date
2022-11-22
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Others : 1. Experimental group 1 : Emotion to Emotion Therapy (ETE) - Emotion to Emotion Therapy (ETE) : Twice a week. (16 times during 8 weeks) - Distribution of Educational Materials on Hwa-byung Ma

Sponsors

Daejeon Korean Medicine Hospital of Daejeon University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Aged 19 to 79 2) Clincally diagnosed with Hwa-byung through a Hwa-byung Diagnostic Interview Schedule (HBDIS) 3) Participants who voluntarily decided to participate and signed the consent form

Exclusion criteria

Exclusion criteria: 1) Participants at risk of suicide (Question no.9 on the BDI has more than 2 points, or with specific suicide thinking or suicide plans) 2) Participants with a history of severe psychiatric disorders (Severe psychiatric disorders refer to psychosis such as hallucinations and delusions. It is decided by a specialist of neuropsychiatry of Korean medicine or a resident of neuropsychiatry of Korean medicine.) 3) Participants who have been treated by Korean medicine to Hwa-byung in recent 4 weeks. 4) Seriously unstable medical conditions (It is decided based on lab tests, vital signs, and etc. by investigator.) 5) Hyperthyrodism or Hypothyrodism (over 2 times the upper reference limit of TSH and Free T4 or below 0.75 times the lower reference limit of TSH and Free T4, or taking medication for hyperthyrodism or hypothyroidism 6) Participants who are thought to be not appropriate to participate in this trial by the investigator.

Design outcomes

Primary

MeasureTime frame
Likert Scale for Major Symptoms of Hwa-byung Symptoms (HB-M)

Secondary

MeasureTime frame
Likert Scale for Major Symptoms of Hwa-byung Symptoms (HB-M);The Core Seven-Emotions Inventory Short From (CSEI-S);Patient Health Questionnaire-15 (PHQ-15);Stress Response Index (SRI);Beck Depression Inventory (BDI);State-Trait Anger Expression Inventory (STAXI);State-Trait Anxiety Inventory (STAI);Insomnia Severity Index;Functional Near-infrared Spectroscopy (fNIRS);Heart Rate Variability (HRV)

Countries

Korea, Republic of

Contacts

Public ContactDong Hoon Kang

Daejeon Korean Medicine Hospital of Daejeon University

eastking@kakao.com+82-42-470-9562

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026